caffeic acid phenethyl ester has been researched along with linoleic acid in 5 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (linoleic acid) | Trials (linoleic acid) | Recent Studies (post-2010) (linoleic acid) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 6,878 | 314 | 2,036 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | linoleic acid (IC50) |
|---|---|---|---|
| Fatty acid-binding protein, heart | Homo sapiens (human) | 1 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 1 | |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 1 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.69 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Bennis, K; Busserolles, J; C Chatelain, F; Chapuy, E; Deokar, H; Ducki, S; Eschalier, A; Lesage, F; Pereira, V; Rodrigues, N; Vivier, D | 1 |
| Chen, Y; Feng, F; Guo, Q; He, S; Liu, W; Liu, Y; Sun, H; Zhao, L | 1 |
| Korshunova, GA; Mirzoeva, OK; Pushkareva, MA; Sud'ina, GF; Sumbatyan, NV; Varfolomeev, SD | 1 |
| Göçer, H; Gülçin, I | 1 |
1 review(s) available for caffeic acid phenethyl ester and linoleic acid
| Article | Year |
|---|---|
Overview of AKR1C3: Inhibitor Achievements and Disease Insights.
Topics: Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Binding Sites; Cell Proliferation; Clinical Trials as Topic; Drug Development; Drug Resistance, Neoplasm; Humans; Models, Molecular; Molecular Structure; Neoplasms; Treatment Outcome | 2020 |
4 other study(ies) available for caffeic acid phenethyl ester and linoleic acid
| Article | Year |
|---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Synthesis and structure-activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel.
Topics: Analgesics; Animals; Caffeic Acids; Cinnamates; Esters; Male; Mice; Models, Molecular; Pain; Potassium Channels, Tandem Pore Domain; Quantitative Structure-Activity Relationship; Xenopus | 2014 |
Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties.
Topics: Antioxidants; Caffeic Acids; Hordeum; Humans; Kinetics; Linoleic Acid; Linoleic Acids; Lipoxygenase Inhibitors; Luminescent Measurements; Neutrophils; Oxidation-Reduction; Phenylethyl Alcohol; Reactive Oxygen Species; Xanthine; Xanthine Oxidase; Xanthines | 1993 |
Caffeic acid phenethyl ester (CAPE): correlation of structure and antioxidant properties.
Topics: Antioxidants; Caffeic Acids; Emulsions; Linoleic Acid; Lipid Peroxidation; Phenylethyl Alcohol; Plant Extracts; Polyphenols; Propolis | 2011 |